Beam Therapeutics Inc. (BEAM) vs MBX Biosciences, Inc. Common Stock (MBX)

A side-by-side comparison of Beam Therapeutics Inc. and MBX Biosciences, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Beam Therapeutics Inc. logo
BEAM
Beam Therapeutics Inc.
$2.65B
$25.72HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
MBX Biosciences, Inc. Common Stock logo
MBX
MBX Biosciences, Inc. Common Stock
$2.73B
$57.29HealthcareDelayed quote: Oct 6, 2026, 11:24 AM EDT

Total return — BEAM vs MBX

growth of $100 · dividends reinvested · last 2y
BEAM -2.4% (-1.2%/yr)MBX +147.5% (+57.3%/yr)MBX compounded faster over this window
100200300Start $10020252026$98$248
BEAM MBX

BEAM vs MBX: by the numbers

  • •MBX is the larger company ($2.73B vs $2.65B market cap).
  • •Both run net losses; MBX's is the smaller (0.00% vs -54.75% net margin).

Metrics side by side

Valuation

MetricBEAMMBX
P/S ratio16.96N/A
P/B ratio2.486.66

Profitability

MetricBEAMMBX
Gross margin84.05%0.00%
Operating margin-274.57%0.00%
Net margin-54.75%0.00%
ROE-8.00%-25.47%
ROIC-28.96%-28.60%

Growth (annualized)

MetricBEAMMBX
Revenue CAGR (5Y)479.04%N/A
Total return CAGR (5Y)-21.41%N/A

Go deeper

Full BEAM analysisFull MBX analysisInteractive comparison tool

Dig into the metrics

Beam Therapeutics ROEMBX Biosciences, Inc. Common Stock ROEBeam Therapeutics operating marginMBX Biosciences, Inc. Common Stock operating marginBeam Therapeutics revenue growthMBX Biosciences, Inc. Common Stock revenue growthBeam Therapeutics free cash flowMBX Biosciences, Inc. Common Stock free cash flow

Beam Therapeutics & MBX Biosciences, Inc. Common Stock appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.